Evaluating the Effectiveness of LACTOFOS in Constipated Patients

NCT01286376 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2011-01-31

No results posted yet for this study

Summary

Determine the effectiveness of symbiotic LACTOFOS containing FOS and probiotics against placebo in patients with a diagnosis of constipation, comparing the average number of weekly evacuations in 2 (two) groups for 30 days.

Conditions

Interventions

DIETARY_SUPPLEMENT

Symbiotic Lactofos

Lactobacillus Paracasei Lactobacillus Rhamnosus Lactobacillus Acidophilus Bifidobacterium lactis 12g/day

DIETARY_SUPPLEMENT

Maltodextrin

Maltodextrin

Sponsors & Collaborators

  • Ganep Human Nutrition

    collaborator OTHER
  • University of Sao Paulo

    lead OTHER

Principal Investigators

  • Dan L. Waitzberg, phd · University of Sao Paulo

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-08-31
Primary Completion
2011-03-31
Completion
2011-08-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01286376 on ClinicalTrials.gov